a developer of molecular diagnostics products and tests that represents a radical new advancement in the understanding of the molecular interactions of DNA
Industry MedicalSpecialties
A.I.dvisor tells us that CODX and ILMN have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CODX and ILMN's prices will move in lockstep.
Ticker / NAME | Correlation To CODX | 1D Price Change % | ||
---|---|---|---|---|
CODX | 100% | -0.90% | ||
ILMN - CODX | 28% Poorly correlated | -2.69% | ||
AEMD - CODX | 27% Poorly correlated | -1.87% | ||
PODD - CODX | 26% Poorly correlated | -2.94% | ||
BNGO - CODX | 26% Poorly correlated | -7.58% | ||
NVCR - CODX | 25% Poorly correlated | -7.38% | ||
More |
Ticker / NAME | Correlation To CODX | 1D Price Change % |
---|---|---|
CODX | 100% | -0.90% |
modules theme (9 stocks) | 25% Poorly correlated | -3.68% |
Medical Specialties theme (427 stocks) | 21% Poorly correlated | -1.53% |
Medical Specialties theme (417 stocks) | 21% Poorly correlated | -1.49% |
drugs theme (254 stocks) | 19% Poorly correlated | -4.03% |
biotechnology theme (238 stocks) | 17% Poorly correlated | -4.32% |
More |